CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Osteoporosis - preventing steroid-induced
In the right clinical topic?
Age from 16 years onwards
This CKS topic is based on the Royal College of Physicians guideline Glucocorticoid-induced osteoporosis [RCP, 2002], and will be updated with the publication of the National Institute for Health and Clinical Excellence guideline Osteoporosis assessment of fracture risk and the prevention of osteoporotic fractures in individuals at high risk, and The use of drugs for the prevention of osteoporotic fragility fractures in women who are on long term systemic corticosteroids treatment.
This CKS topic covers the assessment and management of people taking corticosteroids who have osteoporosis, or who are at risk of osteoporosis.
This CKS topic does not cover the management of people at risk of osteoporosis who are not taking corticosteroids, or the management of postmenopausal women with osteoporosis who are not taking corticosteroids.
There are separate CKS topics on Falls - risk assessment, and Osteoporosis - treatment.
The target audience for this CKS topic is healthcare professionals working within the NHS in England, and providing first contact or primary health care.
© NHS Institute for Innovation and Improvement